Awaiting development: Guidance and quality standards
Showing 1 to 4 of 4
| Title | Type |
|---|---|
| Ensitrelvir for treating COVID 19 [ID6231] | Technology appraisal guidance |
| Remdesivir for treating COVID 19 [ID3808] | Technology appraisal guidance |
| Sabizabulin for treating COVID 19 [TSID11814] | Technology appraisal guidance |
| Vilobelimab for treating COVID 19 [TSID11815] | Technology appraisal guidance |